The Potential Role of Serum IGF-1 and Leptin as Biomarkers: Towards Screening for and Diagnosing Postmenopausal Osteoporosis

References

• Clynes MA, Harvey NC, Curtis EM, et al. The epidemiology of osteoporosis. Br Med Bull. 2020;133:105. doi:10.1093/bmb/ldaa005
   PubMed Web of Science ®Google Scholar
• Rolvien T, Milovanovic P, Schmidt FN. Long-term immobilization in elderly females causes a specific pattern of cortical bone and osteocyte deterioration different from postmenopausal osteoporosis. J Bone Miner Res. 2020;35:1343–1351. doi:10.1002/jbmr.3970
   PubMed Web of Science ®Google Scholar
• Burns RJ, Deschênes SS, Schmitz N. Associations between depressive symptoms and indices of obesity in adults with prediabetes and normal blood glucose levels: results from the emotional health and wellbeing study. Can J Diabetes. 2018;42:626–631. doi:10.1016/j.jcjd.2018.05.005
   PubMed Web of Science ®Google Scholar
• Manolagas SC, O’Brien CA, Almeida M. The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol. 2013;9(12):699–712. doi:10.1038/nrendo.2013.179
   PubMed Web of Science ®Google Scholar
• Li L, Chen X, Lv S, et al. Influence of exercise on bone remodeling-related hormones and cytokines in ovariectomized rats: a model of postmenopausal osteoporosis. PLoS One. 2014;9(11):e112845. doi:10.1371/journal.pone.0112845
   PubMed Web of Science ®Google Scholar
• Mishra GD, Kuh D. Health symptoms during midlife in relation to menopausal transition: British prospective cohort study. BMJ. 2012;344:e402. doi:10.1136/bmj.e402
   PubMed Web of Science ®Google Scholar
• Wang O, Hu Y, Gong S, et al. A survey of outcomes and management of patients post fragility fractures in China. Osteoporos Int. 2015;26:2631–2640. doi:10.1007/s00198-015-3162-6
   PubMed Web of Science ®Google Scholar
• Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994;843:l–129.
   Web of Science ®Google Scholar
• Marcus R. Clinical review 76: the nature of osteoporosis. J Clin Endocrinol Metab. 1996;81:1–5. doi:10.1210/jcem.81.1.8550734
   PubMed Web of Science ®Google Scholar
• Agnusdei D, Gentilella R. GH and IGF-I as therapeutic agents for osteoporosis. J Endocrinol Invest. 2005;28:32–36.
   PubMedGoogle Scholar
• Belfiore A, Frasca F, Pandini G, et al. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev. 2009;30:586–623. doi:10.1210/er.2008-0047
   PubMed Web of Science ®Google Scholar
• Xian L, Wu X, Pang L, et al. Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat Med. 2012;18(7):1095–1101. doi:10.1038/nm.2793
   PubMed Web of Science ®Google Scholar
• Ohlsson C, Mohan S, Sjögren K, et al. The role of liver-derived insulin-like growth factor-I. Endocr Rev. 2009;30:494–535. doi:10.1210/er.2009-0010
   PubMed Web of Science ®Google Scholar
• Seck T, Scheppach B, Scharla S, et al. Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bone matrix from pre- and postmenopausal women: relationship to age, menopause, bone turnover, bone volume, and circulating IGFs. J Clin Endocrinol Metab. 1998;83:2331–2337. doi:10.1210/jcem.83.7.4967
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Kanatani M, Yamauchi M, et al. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, −4, and −5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women. Calcif Tissue Int. 2006;78:18–24. doi:10.1007/s00223-005-0163-z
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Nakano M, Suzuki T, et al. Two adipocytokines, leptin and adiponectin, independently predict osteoporotic fracture risk at different bone sites in postmenopausal women. Bone. 2020;137:115404. doi:10.1016/j.bone.2020.115404
   PubMed Web of Science ®Google Scholar
• Cao JJ. Effects of obesity on bone metabolism. J Orthop Surg Res. 2011;6:30. doi:10.1186/1749-799X-6-30
   PubMed Web of Science ®Google Scholar
• Chen JR, Lazarenko OP, Wu X, et al. Obesity reduces bone density associated with activation of PPARγ and suppression of Wnt/β-catenin in rapidly growing male rats. PLoS One. 2010;5(10):e13704. doi:10.1371/journal.pone.0013704
   PubMed Web of Science ®Google Scholar
• Makki K, Froguel P, Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm. 2013;2013:139239. doi:10.1155/2013/139239
   PubMedGoogle Scholar
• He JY, Jiang LS, Dai LY. The roles of the sympathetic nervous system in osteoporotic diseases: a review of experimental and clinical studies. Ageing Res Rev. 2011;10(2):253–263. doi:10.1016/j.arr.2011.01.002
   PubMed Web of Science ®Google Scholar
• Takeda S, Elefteriou F, Levasseur R, et al. Leptin regulates bone formation via the sympathetic nervous system. Cell. 2002;111(3):305–317. doi:10.1016/S0092-8674(02)01049-8
   PubMed Web of Science ®Google Scholar
• Probst-Hensch NM, Wang H, Goh VH, et al. Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women. Cancer Epidemiol Biomarkers Prev. 2003;12:739–746.
   PubMed Web of Science ®Google Scholar
• Ruhl CE, Everhart JE. Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res. 2002;17:1896–1903. doi:10.1359/jbmr.2002.17.10.1896
   PubMed Web of Science ®Google Scholar
• Sun M, Zhang Y, H. S, et al. Prevalence of and risk factors for community-based osteoporosis and associated fractures in Beijing: study protocol for a cross-sectional and prospective study. Front Med. 2020;7:544697. doi:10.3389/fmed.2020.544697
   Web of Science ®Google Scholar
• Baum E, Peters KM. The diagnosis and treatment of primary osteoporosis according to current guidelines. Dtsch Arztebl Int. 2008;105(33):573–582. doi:10.3238/arztebl.2008.0573
   PubMed Web of Science ®Google Scholar
• Nelson HD. Menopause. Lancet. 2008;371(9614):760–770. doi:10.1016/S0140-6736(08)60346-3
   PubMed Web of Science ®Google Scholar
• Giustina A, Mazziotti G, Canalis E. Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev. 2008;29(5):535–559. doi:10.1210/er.2007-0036
   PubMed Web of Science ®Google Scholar
• Gao L, Gao HZ, Ren Y. The clinical observation of bone metabolic index and cytokine IGF-1 in postmenopausal osteoporosis patients. Chin J Lab Diagn. 2014;18(6):919–921.
   Google Scholar
• Ding L, Li X, Sun H, et al. Transplantation of bone marrow mesenchymal stem cells on collagen scaffolds for the functional regeneration of injured rat uterus. Biomaterials. 2014;35(18):4888–4900. doi:10.1016/j.biomaterials.2014.02.046
   PubMed Web of Science ®Google Scholar
• Ljunghall S, Johansson AG, Burman P, et al. Low plasma levels of insulin-like growth factor 1 (IGF-1) in male patients with idiopathic osteoporosis. J Intern Med. 2010;232(1):59–64. doi:10.1111/j.1365-2796.1992.tb00550.x
   Web of Science ®Google Scholar
• Gordeladze JO, Drevon CA, Syversen U, et al. Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem. 2002;85:825–836. doi:10.1002/jcb.10156
   PubMed Web of Science ®Google Scholar
• Zhao HY, Liu JM, Ning G. Study of relationship between serum leptin level and bone mineral density in postmenopausal women. Shanghai Med. 2004;27:4–7.
   Google Scholar
• Zhong N, Wu XP, Xu ZR, et al. Relationship of serum leptin with age, body weight, body mass index, and bone mineral density in healthy mainland Chinese women. Clin Chim Acta. 2005;351:161–168. doi:10.1016/j.cccn.2004.09.003
   PubMed Web of Science ®Google Scholar